Migraine and tension headache: A complementary and alternative medicine approach

Australian Family Physician

Volumn 34, Issue 8, 2005, Pages 647-650

  Woolhouse, Michelle ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; RIBOFLAVIN;

ACUPUNCTURE; ALTERNATIVE MEDICINE; DIET; DIET SUPPLEMENTATION; DIET THERAPY; ENVIRONMENTAL EXPOSURE; HUMAN; METHODOLOGY; MIGRAINE; PHYTOTHERAPY; RELAXATION TRAINING; REVIEW; RISK FACTOR; SLEEP DISORDER; TANACETUM PARTHENIUM; TENSION HEADACHE;

ACUPUNCTURE THERAPY; COMPLEMENTARY THERAPIES; DIET; DIET THERAPY; DIETARY SUPPLEMENTS; ENVIRONMENTAL EXPOSURE; HUMANS; MAGNESIUM; MIGRAINE DISORDERS; MIND-BODY AND RELAXATION TECHNIQUES; PHYTOTHERAPY; RIBOFLAVIN; RISK FACTORS; SLEEP DISORDERS; TANACETUM PARTHENIUM; TENSION-TYPE HEADACHE;

EID: 26944480088     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Headache Australia website, initiative of the Brain Foundation. Available at: www.headacheaustralia.org.au. Accessed March 2005.
2. Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003;28:9-15.
3. Peatfield RC. Relationship between food, wine and beer: precipitated migrainous headaches. Headache 1995;35:355-7.
4. Egger J, Carter CM, Wilson J, Turner MW, Soothill JF. Is migraine food allergy? A double blind controlled trail of oligo-antigenic diet treatment. Lancet 1983;2:865-9.
5. Hadjivassiliou M, Grunewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM. Headache in CNS white matter abnormalities associated with gluten sensitivity. Neurology 2001;56:385-8.
6. Silverman K. Withdrawal syndrome after the double blind cessation of caffeine consumption. N Engl J Med 1995;327:1109-14.
7. Phipps RA. A comparison of two studies reporting the prevalence of the sick building syndrome in New Zealand and England. NZ Med J 1999;112:228-30.
8. Paiva T, Farinha A, Martins A, Batista A, Guilleminault C. Chronic headaches and sleep disorders. AMA Arch Int Med 1997;157:1701-5.
9. Penzien DB, Rains JC, Andrasik F. Behavioural management of recurrent headache: three decades of experience and empiricism.Appl Psychophysiol Biofeedback 2002;27:163-81.
10. Astin JA. Mind body therapies for the management of pain. Clin J Pain 2004;20:27-32.
11. Duckro PN, Cantwell-Simmonds E. A review of studies evaluating biofeedback and relaxation training in the management of paediatric headache. Headache 1989;29:428-33.
12. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high dose riboflavin in migraine prophylaxis. A randomised controlled trial. Neurology 1998;50:466-70.
13. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004;11:475-7.
14. Breen C. High dose riboflavin for prophylaxis of migraine. Can Fam Physician 2003;49:1291-3.
15. Welch KM, Ramadan NM. Mitochondria, magnesium and migraine. J Neurol Sci 1995;134:9-14.
16. Peikert A. Prophylaxis of migraine with oral magnesium: results from a prospective multi-centre, placebo controlled, double blind, randomised study. Cephalalgia 1996;16:257-63.
17. Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulphate in the treatment of acute migraine attacks. Headache 2001;41:171-7.
18. Pittler MH, Vogler BK, Ernst E. Feverfew for preventing migraine. The Cochrane Database of Systematic Reviews 2001; Issue 4.
19. Melchart D, Linde K, Berman B, White A, Vickers A, Allais G, Brinkhaus B. Acupuncture for idiopathic headache. The Cochrane Database of Systematic Reviews 2001, Issue 1. No: CD001218. DOI: 10.1002/14651858
20. Vickers AJ, Rees RW, Zollman CE, et al. Acupuncture for chronic headache in primary care: large, pragmatic, randomised trail. BMJ 2004;328:744-7.